Russia’s Sputnik Vaccine To Be Manufactured By Tibet’s TopRidge Pharma
The Russian Direct Investment Fund (RDIF) and China’s Tibetan based TopRidge Pharma have agreed to produce over 100 million doses of Russia’s anti-coronavirus vaccine Sputnik V annually in China, the Fund said on Thursday.
“The Russian Direct Investment Fund and TopRidge Pharma (a subsidiary company of one of China’s pharmaceutical market leaders, Tibet Rhodiola Pharmaceutical Holding) have agreed to cooperate on production of over 100 million doses per year of the world’s first registered vaccine against coronavirus Sputnik V in China.” the statement said.
TopRidge Pharma will be able to distribute the vaccine in mainland China, as well as in Hong Kong, Macao and Taiwan, subject to all appropriate regulatory approvals.
The amount of the vaccine that is produced will be sufficient to inoculate over 50 million people, according to the statement. Two shots of the vaccine are required for each individual treatment.
The parties also intend to cooperate on clinical trials of the vaccine in China and promotion of Sputnik V in the country. Sputnik V has been registered in 58 countries globally covering a population of over 1.5 billion people in total. Sputnik V’s efficacy is 91.6% as confirmed by the data published in the Lancet, one of the world’s oldest and most respected medical journals.
- Russia’s Sputnik V Vaccine Destined For EU Markets
- Russia Begins Global Ramp Up Of Covid-19 Sputnik V Vaccine
During these uncertain times, we must stress that our firm does not approve of the Ukraine conflict. We do not entertain business with sanctioned Russian companies or individuals. However, we are well aware of the new emerging supply chains, can advise on strategic analysis and new logistics corridors, and may assist in non-sanctioned areas. We can help, for example, Russian companies develop operations throughout Asia, including banking advisory services, and trade compliance issues, and have done since 1992.
We also provide financial and sanctions compliance services to foreign companies wishing to access Russia. Additionally, we offer market research and advisory services to foreign exporters interested in accessing Russia as the economy looks to replace Western-sourced products. For assistance, please email email@example.com or visit www.dezshira.com